|
C5ORF15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.423550E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.894200E-02 |
| Normal-vs-Stage2 |
1.301600E-02 |
| Normal-vs-Stage3 |
5.112000E-02 |
| Normal-vs-Stage4 |
1.400070E-02 |
| Stage1-vs-Stage2 |
1.305220E-01 |
| Stage1-vs-Stage3 |
6.837200E-01 |
| Stage1-vs-Stage4 |
2.536400E-01 |
| Stage2-vs-Stage3 |
2.592800E-01 |
| Stage2-vs-Stage4 |
7.391200E-01 |
| Stage3-vs-Stage4 |
4.265600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.292000E-02 |
| Normal-vs-AfricanAmerican |
9.471400E-01 |
| Normal-vs-Asian |
3.188400E-01 |
| Caucasian-vs-AfricanAmerican |
1.982580E-01 |
| Caucasian-vs-Asian |
5.435200E-01 |
| AfricanAmerican-vs-Asian |
5.079000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.121900E-03 |
| Normal-vs-Female |
3.178500E-02 |
| Male-vs-Female |
2.820400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.122620E-01 |
| Normal-vs-Age(41-60Yrs) |
1.102250E-02 |
| Normal-vs-Age(61-80Yrs) |
2.959600E-03 |
| Normal-vs-Age(81-100Yrs) |
7.208200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.708800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.644100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.613800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.626400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.915560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.124760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.081400E-01 |
| Classical-VS-Follicular |
3.75539999997176E-06 |
| Classical-VS-Other |
2.433000E-01 |
| Classical-VS-Normal |
3.158200E-01 |
| Tall-VS-Follicular |
7.517600E-03 |
| Tall-VS-Other |
2.478400E-01 |
| Tall-VS-Normal |
5.162400E-01 |
| Follicular-VS-Other |
7.508800E-01 |
| Follicular-VS-Normal |
8.08190000000097E-05 |
| Other-VS-Normal |
1.017620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.856000E-03 |
| Normal-vs-N1 |
3.475500E-02 |
| N0-vs-N1 |
9.371600E-01 |
|
|
